These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 26216230

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. New triple therapy for chronic hepatitis C: real life clinical experience in a community setting.
    Akiyama MJ, Piotrowski JI, Roytman MM, Chan SM, Hong LK, Huddleston L, Trujillo R, Tsai NC.
    Hawaii J Med Public Health; 2013 Sep; 72(9 Suppl 4):6-13. PubMed ID: 24052911
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Boceprevir and telaprevir-based regimens for the treatment of hepatitis C virus in HIV/HCV coinfected patients.
    Beste LA, Green PK, Ioannou GN.
    Eur J Gastroenterol Hepatol; 2015 Feb; 27(2):123-9. PubMed ID: 25503739
    [Abstract] [Full Text] [Related]

  • 26. Boceprevir and telaprevir for chronic genotype 1 hepatitis C virus infection. A systematic review and meta-analysis.
    Manzano-Robleda Mdel C, Ornelas-Arroyo V, Barrientos-Gutiérrez T, Méndez-Sánchez N, Uribe M, Chávez-Tapia NC.
    Ann Hepatol; 2015 Feb; 14(1):46-57. PubMed ID: 25536641
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Efficacy and safety of telaprevir and boceprevir in patients with hepatitis C genotype 1: a meta-analysis.
    Park C, Jiang S, Lawson KA.
    J Clin Pharm Ther; 2014 Feb; 39(1):14-24. PubMed ID: 24237070
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Primary Care-Based Hepatitis C Treatment Outcomes With First-Generation Direct-Acting Agents.
    Woodrell C, Weiss J, Branch A, Gardenier D, Krauskopf K, Kil N, Paredes H, Bichoupan K, Sigel K.
    J Addict Med; 2015 Feb; 9(5):405-10. PubMed ID: 26291545
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Triple therapy with boceprevir or telaprevir for treatment naïve HCV patients.
    Esteban R, Buti M.
    Best Pract Res Clin Gastroenterol; 2012 Aug; 26(4):445-53. PubMed ID: 23199503
    [Abstract] [Full Text] [Related]

  • 34. Safety and efficacy of protease inhibitor based combination therapy in a single-center "real-life" cohort of 110 patients with chronic hepatitis C genotype 1 infection.
    Wehmeyer MH, Eißing F, Jordan S, Röder C, Hennigs A, Degen O, Hüfner A, Hertling S, Schmiedel S, Sterneck M, van Lunzen J, Lohse AW, Schulze zur Wiesch J, Lüth S.
    BMC Gastroenterol; 2014 May 05; 14():87. PubMed ID: 24884400
    [Abstract] [Full Text] [Related]

  • 35. The future for the treatment of genotype 4 chronic hepatitis C.
    Esmat G, El Raziky M, El Kassas M, Hassany M, Gamil ME.
    Liver Int; 2012 Feb 05; 32 Suppl 1():146-50. PubMed ID: 22212586
    [Abstract] [Full Text] [Related]

  • 36. Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis.
    Saxena V, Manos MM, Yee HS, Catalli L, Wayne E, Murphy RC, Shvachko VA, Pauly MP, Chua J, Monto A, Terrault NA.
    Aliment Pharmacol Ther; 2014 May 05; 39(10):1213-24. PubMed ID: 24654657
    [Abstract] [Full Text] [Related]

  • 37. Effectiveness of telaprevir and boceprevir triple therapy for patients with hepatitis C virus infection in a large integrated care setting.
    Price JC, Murphy RC, Shvachko VA, Pauly MP, Manos MM.
    Dig Dis Sci; 2014 Dec 05; 59(12):3043-52. PubMed ID: 25102983
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of the prognostic value of liver stiffness in patients with hepatitis C virus treated with triple or dual antiviral therapy: A prospective pilot study.
    Stasi C, Piluso A, Arena U, Salomoni E, Montalto P, Monti M, Boldrini B, Corti G, Marra F, Laffi G, Milani S, Zignego AL.
    World J Gastroenterol; 2015 Mar 14; 21(10):3013-9. PubMed ID: 25780300
    [Abstract] [Full Text] [Related]

  • 39. Comparative effectiveness of the hepatitis C virus protease inhibitors boceprevir and telaprevir in a large U.S. cohort.
    Backus LI, Belperio PS, Shahoumian TA, Cheung R, Mole LA.
    Aliment Pharmacol Ther; 2014 Jan 14; 39(1):93-103. PubMed ID: 24206566
    [Abstract] [Full Text] [Related]

  • 40. [Progress in hepatitis C treatment].
    Vinaixa C, Aguilera V, Berenguer M.
    Med Clin (Barc); 2013 Nov 16; 141(10):447-52. PubMed ID: 23601737
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.